Sana Biotechnology
SANA • NASDAQ
Sana Biotechnology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Steven D. Harr, with a market cap of $739.2M.
CEOSteven D. Harr
Next Earnings
Upcoming earnings announcement for Sana Biotechnology
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.15
Earnings History
Past 12 earnings reports for Sana Biotechnology
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Q4 2025 | -$0.16Est: -$0.13 | -23.1% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.15Est: -$0.19 | +21.1% | - | — | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.16Est: -$0.21 | +23.8% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.20 | — | - | — | 10-Q |
| Mar 17, 2025 | Q4 2024 | -$0.23Est: -$0.26 | +11.5% | - | — | 10-K |
| Nov 8, 2024 | Q3 2024 | -$0.27Est: -$0.27 | 0.0% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.32Est: -$0.28 | -14.3% | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.32Est: -$0.32 | 0.0% | - | — | 10-Q |
| Feb 29, 2024 | Q4 2023 | -$0.35Est: -$0.38 | +7.9% | - | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.41Est: -$0.45 | +8.9% | - | — | — |
| Aug 3, 2023 | Q2 2023 | -$0.45Est: -$0.43 | -4.7% | - | — | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.43Est: -$0.45 | +4.4% | - | — | — |